Sporting $100 leggings… from Shanghai to the Champs-Élysées. Lululemon’s stretching its presence overseas in search of fresh $$. Last quarter the athleisure icon’s sales and profit jumped, while revenue from China soared 70% as the country reopened. Lulu plans to triple stores in China, which it expects to be its second-largest market by 2026. In the US, Lulu’s “experiential stores” (see: hot-yoga class next to the yoga-pants rack) have boosted foot traffic. Analysts also expect hot earnings when Lulu reports tomorrow.
Stuck in the middle with two… political parties. Walgreens is set to report tomorrow as it finds itself at the center of the abortion-pill debate. The pharmacy recently said it wouldn't sell the pill in 20 GOP-led states, including some where abortion’s still legal. In response, California said it wouldn’t renew a $54M contract with Walgreens — a drop in the chain's $132B annual sales, but a symbolic move. Meanwhile, Walgreens’ sales were down at the start of the year as Covid-test sales trailed off and vaccinations slowed.